Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 369,000 | 74,000 | 1,204,000 | 1,149,000 | 667,000 |
| Depreciation Amortization | 55,000 | 29,000 | 71,000 | 50,000 | 32,000 |
| Accounts receivable | -101,000 | 158,000 | -166,000 | -124,000 | -77,000 |
| Other Working Capital | -380,000 | -113,000 | 225,000 | -28,000 | -30,000 |
| Other Operating Activity | 111,000 | -145,000 | -148,000 | -162,000 | -243,000 |
| Operating Cash Flow | $54,000 | $3,000 | $1,186,000 | $885,000 | $349,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 1,631,000 | -26,000 | 26,000 |
| PPE Investments | -7,000 | -5,000 | -7,252,000 | -24,000 | -22,000 |
| Purchase Of Investment | -4,000 | -4,000 | -4,000 | -3,000 | -3,000 |
| Sale Of Investment | 5,000 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -1,000 | N/A | -18,000 | -18,000 | -18,000 |
| Other Investing Activity | -1,000 | 0 | -18,000 | -18,000 | -18,000 |
| Investing Cash Flow | $-7,000 | $-9,000 | $-5,643,000 | $-71,000 | $-17,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | -63,000 | 5,500,000 | N/A | N/A |
| Debt Repayment | -125,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 3,000 | 2,000 | 23,000 | 16,000 | 7,000 |
| Common Stock Repurchased | -96,000 | -96,000 | -430,000 | N/A | -406,000 |
| Other Financing Activity | -34,000 | -20,000 | -304,000 | -456,000 | -20,000 |
| Financing Cash Flow | $-252,000 | $-177,000 | $4,789,000 | $-440,000 | $-419,000 |
| Exchange Rate Effect | -7,000 | -11,000 | 3,000 | 7,000 | 3,000 |
| Beginning Cash Position | 1,715,000 | 1,715,000 | 1,380,000 | 1,380,000 | 1,380,000 |
| End Cash Position | 1,503,000 | 1,521,000 | 1,715,000 | 1,761,000 | 1,296,000 |
| Net Cash Flow | $-212,000 | $-194,000 | $335,000 | $381,000 | $-84,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 54,000 | 3,000 | 1,186,000 | 885,000 | 349,000 |
| Capital Expenditure | -7,000 | -5,000 | -7,252,000 | -24,000 | -22,000 |
| Free Cash Flow | 47,000 | -2,000 | -6,066,000 | 861,000 | 327,000 |